AnalystsMadhu KumarMadhu Kumar's Stock Forecasts
AnalystsMadhu Kumar
Analyst Ranking
Top 2%
#49 out of 3772 analysts
Average Return
+30.62%
Win Rate
58%35 out of 60
Risk vs Reward
Poor
Good
Madhu Kumar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
CATALYST BIOSCIENCES INCCBIO | +450.00% | $4.38 | $24.09 | 2017-06-12 - 2018-06-12 | Strong Buy |
SCHOLAR ROCK HOLDING CORPSRRK | +331.26% | $14.97 | $64.56 | 2020-03-12 - 2021-03-12 | Buy |
ARBUTUS BIOPHARMA CORPABUS | +309.92% | $1.21 | $4.96 | 2020-03-27 - 2020-07-24 | Buy |
CLEMENTIA PHARMACEUTICALS INCCMTA | +211.47% | $8.46 | $26.35 | 2018-08-15 - 2019-04-17 | Strong Buy |
ARCTURUS THERAPEUTICS HOLDINGS INCARCT | +206.96% | $13.80 | $42.36 | 2020-02-11 - 2020-12-29 | Buy |
Madhu Kumar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
REATA PHARMACEUTICALS INCRETA | 2 | Strong Buy | $73.00 | +134.88% | Maintains | a month ago |
EDGEWISE THERAPEUTICS INCEWTX | 1 | Hold | $8.00 | -6.21% | Maintains | a month ago |
TRICIDA INCTCDA | 1 | Strong Buy | $25.00 | +158.80% | Initiates Coverage On | 2 months ago |
ALECTOR INCALEC | 1 | Strong Sell | $9.00 | -16.12% | Initiates Coverage On | 2 months ago |
JAZZ PHARMACEUTICALS PLCJAZZ | 1 | Hold | $196.00 | +27.70% | Downgrades | 3 months ago |
CEREVEL THERAPEUTICS HOLDINGS INCCERE | 1 | Hold | $27.00 | -4.09% | Initiates Coverage On | 4 months ago |
SYNDAX PHARMACEUTICALS INCSNDX | 2 | Strong Buy | $37.00 | +93.41% | Initiates Coverage On | 4 months ago |
PASSAGE BIO INCPASG | 1 | Hold | $6.00 | +135.29% | Downgrades | 5 months ago |
ARROWHEAD PHARMACEUTICALS INCARWR | 5 | Strong Buy | N/A | N/A | Upgrades | 5 months ago |
DESIGN THERAPEUTICS INCDSGN | 1 | Strong Sell | $10.00 | -34.43% | Initiates Coverage On | 5 months ago |
ARVINAS INCARVN | 1 | Strong Buy | $157.00 | +242.79% | Initiates Coverage On | 5 months ago |
MAGENTA THERAPEUTICS INCMGTA | 1 | Strong Buy | $8.00 | +515.38% | Upgrades | 6 months ago |
HORIZON THERAPEUTICS PUBLIC LTD COHZNP | 1 | Strong Buy | $168.00 | +97.35% | Upgrades | 7 months ago |
APPLIED THERAPEUTICS INCAPLT | 1 | Strong Sell | $10.00 | +1,083.43% | Downgrades | 10 months ago |
DICERNA PHARMACEUTICALS INCDRNA | 5 | Hold | $25.00 | -34.59% | Downgrades | 10 months ago |
ARCTURUS THERAPEUTICS HOLDINGS INCARCT | 3 | Strong Sell | $29.00 | +79.68% | Downgrades | 10 months ago |
DYNAVAX TECHNOLOGIES CORPDVAX | 1 | Strong Buy | $19.00 | +54.10% | Initiates Coverage On | a year ago |
KRYSTAL BIOTECH INCKRYS | 1 | Strong Buy | $90.00 | +31.35% | Upgrades | a year ago |
INTELLIA THERAPEUTICS INCNTLA | 5 | Hold | $85.00 | N/A | Maintains | a year ago |
IOVANCE BIOTHERAPEUTICS INCIOVA | 2 | Strong Buy | $97.00 | N/A | Initiates Coverage On | a year ago |
APELLIS PHARMACEUTICALS INCAPLS | 5 | Strong Buy | $130.00 | N/A | Initiates Coverage On | a year ago |
EDITAS MEDICINE INCEDIT | 3 | Strong Sell | $20.00 | N/A | Initiates Coverage On | a year ago |
CELLECTIS SACLLS | 2 | Buy | $39.00 | N/A | Upgrades | a year ago |
GRITSTONE BIO INCGRTS | 1 | Sell | $8.00 | N/A | Downgrades | a year ago |
CELLULAR BIOMEDICINE GROUP INCCBMG | 2 | Hold | $19.00 | N/A | Downgrades | 2 years ago |
UNIQURE NVQURE | 2 | Buy | $57.00 | N/A | Upgrades | 2 years ago |
ARBUTUS BIOPHARMA CORPABUS | 8 | Hold | N/A | N/A | Downgrades | 2 years ago |
APREA THERAPEUTICS INCAPRE | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
VIR BIOTECHNOLOGY INCVIR | 1 | Sell | $20.00 | N/A | Maintains | 2 years ago |
PIERIS PHARMACEUTICALS INCPIRS | 1 | Buy | $5.00 | N/A | Upgrades | 2 years ago |
SCHOLAR ROCK HOLDING CORPSRRK | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
LEAP THERAPEUTICS INCLPTX | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
SPARK THERAPEUTICS INCONCE | 1 | Strong Buy | $71.00 | N/A | Upgrades | 4 years ago |
EYEPOINT PHARMACEUTICALS INCEYPT | 1 | Strong Buy | $6.00 | N/A | Maintains | 4 years ago |
ASSEMBLY BIOSCIENCES INCASMB | 3 | Strong Buy | $42.00 | N/A | Upgrades | 4 years ago |
TETRAPHASE PHARMACEUTICALS INCTTPH | 1 | Strong Buy | $7.00 | N/A | Maintains | 4 years ago |
IMMUNOMEDICS INCIMMU | 1 | Strong Buy | $55.00 | N/A | Maintains | 4 years ago |
CLEMENTIA PHARMACEUTICALS INCCMTA | 2 | Strong Buy | $16.00 | N/A | Maintains | 4 years ago |
ALNYLAM PHARMACEUTICALS INCALNY | 2 | Strong Buy | $230.00 | N/A | Maintains | 4 years ago |
REGULUS THERAPEUTICS INCRGLS | 3 | Hold | $0.50 | N/A | Maintains | 4 years ago |
DECIPHERA PHARMACEUTICALS INCDCPH | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
CATALYST BIOSCIENCES INCCBIO | 2 | Strong Buy | $75.00 | N/A | Maintains | 4 years ago |
INFLARX NVIFRX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
AKARI THERAPEUTICS PLCAKTX | 3 | Hold | $3.00 | N/A | Initiates Coverage On | 4 years ago |
ACHILLION PHARMACEUTICALS INCACHN | 1 | Hold | $3.50 | N/A | Initiates Coverage On | 4 years ago |
TG THERAPEUTICS INCTGTX | 1 | Strong Buy | $21.50 | N/A | Reinstates | 5 years ago |
CRISPR THERAPEUTICS AGCRSP | 1 | Strong Buy | $23.50 | N/A | Initiates Coverage On | 5 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.